BPC-157 5 & 10mg
A synthetic 15-amino-acid sequence derived from a protein found in human gastric juice, supplied lyophilized for in vitro tissue-protection and angiogenesis research.
Certificate of Analysis
Compound information
What is BPC-157?
A synthetic 15-amino-acid pentadecapeptide (GEPPPGKPADDAGLV) derived from a protein found in human gastric juice — studied as a stable, research-grade tool compound in tissue-repair and cytoprotection work.
BPC-157 structure
Stability information
Product overview
High-stability pentadecapeptide supplied for laboratory evaluation at a ≥99% HPLC analytical standard.
Technical overview
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV) corresponding to a partial sequence of a protein found in human gastric juice. Notably stable in gastric juice, it is studied as a tool compound for tissue-protection and cytoprotection research.
It is manufactured by solid-phase peptide synthesis and multi-stage purification, then released against a lot-matched Certificate of Analysis carrying HPLC purity and LC-MS identity.
Research applications
Common laboratory applications include gastric and intestinal mucosal-injury models, tendon and ligament fibroblast cultures, endothelial angiogenesis assays, and rodent Achilles & medial-collateral-ligament transection models. Mechanistic interest centres on nitric-oxide / VEGFR2 signalling and the FAK-paxillin pathway.
Kylo Peptides supplies this compound as a reference material for scientific inquiry. All applications must be conducted by qualified professionals in controlled laboratory environments. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions About BPC-157
BPC-157 is a stable synthetic pentadecapeptide studied as a tool compound in tissue-repair and cytoprotection research. In vitro and preclinical work uses it in gastric and intestinal mucosal-injury models, tendon and ligament fibroblast cultures, endothelial angiogenesis assays, and central and peripheral nervous-system injury models, examining nitric-oxide, FAK-paxillin, and growth-factor receptor pathways.
≥99% pure by HPLC-UV — the latest released lot tested 99.62%, with identity confirmed by LC-MS and a measured net peptide content of 12.14 mg in a 10 mg vial. Every lot is released against an independent third-party full QC panel — HPLC purity, LC-MS identity, net peptide content, heavy metals (ICP-MS), sterility, and endotoxin (USP <85>) — with a lot-specific COA matched to the lot number printed on the vial.
The CAS number is 137525-51-0 and the PubChem CID is 9941957. The molecule is also cataloged as Body Protection Compound 157, Pentadecapeptide BPC-157, PL 14736, and Bepecin, with the sequence GEPPPGKPADDAGLV and a molecular weight of 1419.55 g/mol.
Hold the lyophilized vial at −20 °C, sealed and protected from light and moisture. Store sealed aliquots at −20 °C or below for longer storage; avoid repeated freeze-thaw cycles.
No. The research-grade BPC-157 supplied by Kylo Peptides is for in vitro laboratory study only. It is not formulated, packaged, or labeled for human or veterinary use, and it is not an FDA-approved drug.
Yes. The lot-specific Certificate of Analysis is published in our public COA library and matched to the lot ID printed on the vial, covering HPLC purity, LC-MS identity, net peptide content, heavy metals (ICP-MS), sterility, and endotoxin (USP <85>) from an independent third-party laboratory.
BPC-157 is not FDA-approved. In September 2023 the FDA placed it in Category 2 of its 503A interim bulk-substances policy, effectively excluding it from the compounding bulk-substances list, so it is not eligible for pharmacy compounding for human use. The material supplied here is research-grade, for in vitro laboratory study only.
Backed By A Lot-Matched COA
Every BPC-157 order ships with a certificate of analysis tied to the exact lot in your vial.
Shop catalog →